Gary Sibbet

2.3k total citations
29 papers, 1.8k citations indexed

About

Gary Sibbet is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Gary Sibbet has authored 29 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Gary Sibbet's work include Ubiquitin and proteasome pathways (16 papers), Cancer-related Molecular Pathways (7 papers) and Virus-based gene therapy research (5 papers). Gary Sibbet is often cited by papers focused on Ubiquitin and proteasome pathways (16 papers), Cancer-related Molecular Pathways (7 papers) and Virus-based gene therapy research (5 papers). Gary Sibbet collaborates with scholars based in United Kingdom, United States and Netherlands. Gary Sibbet's co-authors include Danny T. Huang, Lori Buetow, Vaughn Cleghon, Hao Dou, Pamela A. Lochhead, Nick Morrice, Kenneth Cameron, M. Saveria Campo, Ross Kinstrie and Mads Gabrielsen and has published in prestigious journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Gary Sibbet

28 papers receiving 1.8k citations

Peers

Gary Sibbet

ONCOL

EPIDE

IMMUN

Gregory M. Shackleford United States

Klaas W. Mulder Netherlands

Elias Coutavas United States

Rickard Glas Sweden

Meg Trahey United States

Roderick Bronson United States

Alexandre David France

Emma W Vaimberg United States

Stéphanie Pébernard Switzerland

Charlotte A. Spencer Canada

Gregory M. Shackleford United States

Gary Sibbet

1.8k ×1.4

408 ×0.8

ONCOL

161 ×0.5

EPIDE

239 ×1.0

IMMUN

222 ×1.0

Citations per year, relative to Gary Sibbet Gary Sibbet (= 1×) peers Gregory M. Shackleford

Countries citing papers authored by Gary Sibbet

Since Specialization

Citations

This map shows the geographic impact of Gary Sibbet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Sibbet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Sibbet more than expected).

Fields of papers citing papers by Gary Sibbet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Sibbet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Sibbet. The network helps show where Gary Sibbet may publish in the future.

Co-authorship network of co-authors of Gary Sibbet

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Sibbet. A scholar is included among the top collaborators of Gary Sibbet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Sibbet. Gary Sibbet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ahmed, Syed Feroj, Wei Zhang, Lori Buetow, et al.. (2025). Locking CBL TKBD in its native conformation presents a novel therapeutic opportunity in mutant CBL-dependent leukemia. Molecular Therapy. 33(8). 3624–3643.

Nakasone, Mark A., K.A. Majorek, Mads Gabrielsen, et al.. (2022). Structure of UBE2K–Ub/E3/polyUb reveals mechanisms of K48-linked Ub chain extension. Nature Chemical Biology. 18(4). 422–431. 30 indexed citations

Ahmed, Syed Feroj, Lori Buetow, Mads Gabrielsen, et al.. (2021). E3 ligase-inactivation rewires CBL interactome to elicit oncogenesis by hijacking RTK–CBL–CIN85 axis. Oncogene. 40(12). 2149–2164. 8 indexed citations

Chatrin, Chatrin, Mads Gabrielsen, Lori Buetow, et al.. (2020). Structural insights into ADP-ribosylation of ubiquitin by Deltex family E3 ubiquitin ligases. Science Advances. 6(38). 67 indexed citations

Ahmed, Syed Feroj, Lori Buetow, Mads Gabrielsen, et al.. (2020). DELTEX2 C-terminal domain recognizes and recruits ADP-ribosylated proteins for ubiquitination. Science Advances. 6(34). 55 indexed citations

Ahmed, Syed Feroj, Gary Sibbet, Ventzislava A. Hristova, et al.. (2020). Structural basis for DNA damage-induced phosphoregulation of MDM2 RING domain. Nature Communications. 11(1). 2094–2094. 28 indexed citations

Sibbet, Gary, et al.. (2018). Structural insights into non-covalent ubiquitin activation of the cIAP1-UbcH5B∼ubiquitin complex. Journal of Biological Chemistry. 294(4). 1240–1249. 15 indexed citations

Nomura, Koji, et al.. (2017). Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity. Nature Structural & Molecular Biology. 24(7). 578–587. 53 indexed citations

Gabrielsen, Mads, Lori Buetow, Mark A. Nakasone, et al.. (2017). A General Strategy for Discovery of Inhibitors and Activators of RING and U-box E3 Ligases with Ubiquitin Variants. Molecular Cell. 68(2). 456–470.e10. 54 indexed citations

10.

Buetow, Lori, Giancarlo Tria, Syed Feroj Ahmed, et al.. (2016). Casitas B-lineage lymphoma linker helix mutations found in myeloproliferative neoplasms affect conformation. BMC Biology. 14(1). 76–76. 15 indexed citations

11.

Spender, Lindsay C., Gail Ferguson, Sijia Liu, et al.. (2016). Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells. Oncotarget. 7(50). 81995–82012. 18 indexed citations

12.

Buetow, Lori, Mads Gabrielsen, Nahoum G. Anthony, et al.. (2015). Activation of a Primed RING E3-E2–Ubiquitin Complex by Non-Covalent Ubiquitin. Molecular Cell. 58(2). 297–310. 104 indexed citations

13.

Dou, Hao, Lori Buetow, Gary Sibbet, Kenneth Cameron, & Danny T. Huang. (2013). Essentiality of a non-RING element in priming donor ubiquitin for catalysis by a monomeric E3. Nature Structural & Molecular Biology. 20(8). 982–986. 107 indexed citations

14.

Dou, Hao, Lori Buetow, Gary Sibbet, Kenneth Cameron, & Danny T. Huang. (2012). BIRC7–E2 ubiquitin conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer. Nature Structural & Molecular Biology. 19(9). 876–883. 258 indexed citations

15.

Dou, Hao, Lori Buetow, Andreas Hock, et al.. (2012). Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl. Nature Structural & Molecular Biology. 19(2). 184–192. 146 indexed citations

16.

Han, Jingfen, Diego Miranda‐Saavedra, Nathan Luebbering, et al.. (2012). Deep Evolutionary Conservation of an Intramolecular Protein Kinase Activation Mechanism. PLoS ONE. 7(1). e29702–e29702. 18 indexed citations

17.

Lochhead, Pamela A., Gary Sibbet, Nick Morrice, & Vaughn Cleghon. (2005). Activation-Loop Autophosphorylation Is Mediated by a Novel Transitional Intermediate Form of DYRKs. Cell. 121(6). 925–936. 238 indexed citations

18.

Ashrafi, G. Hossein, Emmanouella Tsirimonaki, Barbara Marchetti, et al.. (2002). Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene. 21(2). 248–259. 94 indexed citations

19.

Cuthill, Scott, Gary Sibbet, & M. Saveria Campo. (1993). Characterization of a nuclear factor, papilloma enhancer binding factor‐1, that binds the long control region of human papillomavirus type 16 and contributes to enhancer activity. Molecular Carcinogenesis. 8(2). 96–104. 18 indexed citations

20.

Sibbet, Gary & M. Saveria Campo. (1990). Multiple interactions between cellular factors and the non-coding region of human papillomavirus type 16. Journal of General Virology. 71(11). 2699–2707. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact